You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...

Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, Groningen 9747 AG, The Netherlands Zernike Institute for Advanced Materials, University of Groningen, Nijenborgh 4, Groningen ...

About R-107 R-107 is an innovative proprietary extended-release oral tablet of racemic ketamine, being developed as a monotherapy for Treatment-Resistant Depression (TRD). Poised to be the first ...

Lee is Associate Professor in Materials Chemistry. Lee completed his PhD in Materials Chemistry at the Royal Institution of Great Britain, and he was awarded the Ramsay Medal by University College ...

Tasman's R-107 is an investigational, Phase 3, extended-release, oral ketamine tablet and monotherapy for patients with treatment resistant depression ("TRD"). BEDROC Phase 2 randomized, placebo ...

About R-107 R-107 is an innovative proprietary extended-release oral tablet of racemic ketamine, being developed as a monotherapy for Treatment-Resistant Depression (TRD). Poised to be the first oral ...